A review of clinical characteristics and genetic backgrounds in Alport syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of clinical characteristics and genetic backgrounds in Alport syndrome
Authors
Keywords
Genotype–phenotype correlation, Thin basement membrane, ACE inhibitor, Bardoxolone
Journal
Clinical and Experimental Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-20
DOI
10.1007/s10157-018-1629-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases
- (2018) China Nagano et al. Clinical and Experimental Nephrology
- Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome
- (2018) Tomoko Horinouchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group
- (2018) Clifford E. Kashtan et al. KIDNEY INTERNATIONAL
- Modulation of aberrant splicing in human RNA diseases by chemical compounds
- (2017) Naoyuki Kataoka HUMAN GENETICS
- Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis
- (2017) Kandai Nozu et al. JOURNAL OF HUMAN GENETICS
- Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome
- (2016) N. Kamiyoshi et al. Clinical Journal of the American Society of Nephrology
- Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome
- (2016) Dafni Moschidou et al. STEM CELLS AND DEVELOPMENT
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene
- (2015) Xue Jun Fu et al. Clinical and Experimental Nephrology
- End-stage renal disease in Japanese children: a nationwide survey during 2006–2011
- (2015) Motoshi Hattori et al. Clinical and Experimental Nephrology
- Ocular Features in Alport Syndrome: Pathogenesis and Clinical Significance
- (2015) J. Savige et al. Clinical Journal of the American Society of Nephrology
- Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome
- (2015) Xue Jun Fu et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- X-Linked Alport Syndrome Caused by Splicing Mutations in COL4A5
- (2014) K. Nozu et al. Clinical Journal of the American Society of Nephrology
- Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis
- (2014) Andrew F. Malone et al. KIDNEY INTERNATIONAL
- End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases
- (2014) A. Mallett et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Natural history of genetically proven autosomal recessive Alport syndrome
- (2014) Masafumi Oka et al. PEDIATRIC NEPHROLOGY
- Cyclosporin A may cause injury to undifferentiated glomeruli persisting in patients with Alport syndrome
- (2013) Keisuke Sugimoto et al. Clinical and Experimental Nephrology
- COL4A3/COL4A4 Mutations and Features in Individuals with Autosomal Recessive Alport Syndrome
- (2013) H. Storey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy
- (2013) J. Savige et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain
- (2013) Yuya Hashimura et al. KIDNEY INTERNATIONAL
- Ataluren as an Agent for Therapeutic Nonsense Suppression
- (2012) Stuart W. Peltz et al. Annual Review of Medicine
- Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome
- (2012) Nicholas J. A. Webb et al. PEDIATRIC NEPHROLOGY
- Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
- (2011) Oliver Gross et al. KIDNEY INTERNATIONAL
- Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial
- (2011) N. J. A. Webb et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mutations in the human laminin β2 (LAMB2) gene and the associated phenotypic spectruma
- (2010) Verena Matejas et al. HUMAN MUTATION
- Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
- (2010) Mari Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Genotype-Phenotype Correlation in X-Linked Alport Syndrome
- (2010) M. R. Bekheirnia et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cyclosporine A treatment in patients with Alport syndrome: a single-center experience
- (2010) Laura Massella et al. PEDIATRIC NEPHROLOGY
- A family with X-linked benign familial hematuria
- (2009) Kazunari Kaneko et al. PEDIATRIC NEPHROLOGY
- X Inactivation, Female Mosaicism, and Sex Differences in Renal Diseases
- (2008) B. R. Migeon JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome
- (2008) R. P. Krol et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More